These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37235819)

  • 1. Early-Onset GI Cancers: Rising Trends, Genetic Risks, Novel Strategies, and Special Considerations.
    Harrold E; Latham A; Pemmaraju N; Lieu CH
    Am Soc Clin Oncol Educ Book; 2023 May; 43():e398068. PubMed ID: 37235819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical Considerations in Diagnosing and Managing Early-Onset GI Cancers.
    Lumish MA; Cercek A
    J Clin Oncol; 2022 Aug; 40(24):2662-2680. PubMed ID: 35839438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPARC and DNA methylation: possible diagnostic and therapeutic implications in gastrointestinal cancers.
    Nagaraju GP; El-Rayes BF
    Cancer Lett; 2013 Jan; 328(1):10-7. PubMed ID: 22939997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
    Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
    Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological Trends of GI Cancers in Patients Visiting a Tertiary Care Hospital in Chandigarh, North India.
    Sharma MK; Singh T; Pandey AK; Kankaria A
    Asian Pac J Cancer Prev; 2015; 16(8):3499-503. PubMed ID: 25921168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descriptive Epidemiology of Gastrointestinal Cancers: Results from National Cancer Registry Programme, India.
    S ST; Krishnan SK; Das P; Sudarshan KL; Kotian CM; Santhappan S; Vishwakarma MB; N S; Mathur P
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):409-418. PubMed ID: 35225451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and Projections in National United States Health Care Spending for Gastrointestinal Malignancies (1996-2030).
    Stukalin I; Ahmed NS; Fundytus AM; Qian AS; Coward S; Kaplan GG; Hilsden RJ; Burak KW; Lee JK; Singh S; Ma C
    Gastroenterology; 2022 Apr; 162(4):1098-1110.e2. PubMed ID: 34922947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of GI Tumor Board on Patient Management and Adherence to Guidelines.
    AlFarhan HA; Algwaiz GF; Alzahrani HA; Alsuhaibani RS; Alolayan A; Abdelhafiz N; Ali Y; Boghdadly S; Jazieh AR
    J Glob Oncol; 2018 Sep; 4():1-8. PubMed ID: 30241257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of HIV on Non-AIDS defining gastrointestinal malignancies: A review.
    Pumpalova YS; Segall L; Felli R; Bhatkhande G; Jacobson JS; Neugut AI
    Semin Oncol; 2021 Jun; 48(3):226-235. PubMed ID: 34593219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upper gastrointestinal cancer predisposition syndromes.
    Shah MA; Kurtz RC
    Hematol Oncol Clin North Am; 2010 Oct; 24(5):815-35. PubMed ID: 20816576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy in Gastrointestinal Malignancies.
    Surana R; Pant S
    Adv Exp Med Biol; 2021; 1342():259-272. PubMed ID: 34972968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Special Series: Advances in GI Cancer.
    Meyerhardt JA; Tepper JE; Venook AP
    J Clin Oncol; 2015 Jun; 33(16):1717-20. PubMed ID: 25918284
    [No Abstract]   [Full Text] [Related]  

  • 14. Current approaches to immunotherapy in noncolorectal gastrointestinal malignancies.
    Jesus VHF; Felismino TC; Barros E Silva MJ; Souza E Silva V; Riechelmann RP
    Clinics (Sao Paulo); 2018 Oct; 73(suppl 1):e510s. PubMed ID: 30365605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary Gastrointestinal Cancer Syndromes: Role of Imaging in Screening, Diagnosis, and Management.
    Katabathina VS; Menias CO; Khanna L; Murphy L; Dasyam AK; Lubner MG; Prasad SR
    Radiographics; 2019; 39(5):1280-1301. PubMed ID: 31373866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A viral map of gastrointestinal cancers.
    Costa NR; Gil da Costa RM; Medeiros R
    Life Sci; 2018 Apr; 199():188-200. PubMed ID: 29476768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening in GI Cancers: The Role of Genetics.
    Stoffel EM
    J Clin Oncol; 2015 Jun; 33(16):1721-8. PubMed ID: 25918283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-Onset Cancer in the Gastrointestinal Tract Is on the Rise-Evidence and Implications.
    Ben-Aharon I; van Laarhoven HWM; Fontana E; Obermannova R; Nilsson M; Lordick F
    Cancer Discov; 2023 Mar; 13(3):538-551. PubMed ID: 36757194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gastrointestinal microbiota and its role in oncogenesis.
    Lam SY; Yu J; Wong SH; Peppelenbosch MP; Fuhler GM
    Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):607-618. PubMed ID: 29566903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk between oxidative stress signaling and microRNA regulatory systems in carcinogenesis: Focused on gastrointestinal cancers.
    Akbari A; Majd HM; Rahnama R; Heshmati J; Morvaridzadeh M; Agah S; Amini SM; Masoodi M
    Biomed Pharmacother; 2020 Nov; 131():110729. PubMed ID: 33152911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.